The UK is committed to rapid equitable access to safe and effective vaccines. We are among the largest donors to the COVAX Advance Market Commitment, committing £548 million. The UK is also donating 80% of its surplus vaccines to COVAX. This support to COVAX has been critical to it supplying COVID-19 vaccines to over 120 countries and economies, including Tunisia. By the end of June, Tunisia received over 760,000 doses from COVAX and will eventually receive 20% of their entire national requirement from COVAX absolutely free.